Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Thu, 07/30/2020 - 06:08	Opened		Gäst
Newsletter clicked	Thu, 07/30/2020 - 06:08	Clicked https://japan.progress.im/ja/content/covid-19%E3%83%91%E3%83%B3%E3%83%87%E3%83%9F%E3%83%83%E3%82%AF%E4%B8%AD%E3%81%AB%E5%A6%8A%E5%A9%A6%E3%81%8A%E3%82%88%E3%81%B3%E7%94%A3%E5%BE%8C%E3%81%AE%E5%A5%B3%E6%80%A7%E3%81%A7%E6%8A%91%E3%81%86%E3%81%A4%E3%81%		Gäst
Newsletter opened	Thu, 07/30/2020 - 06:08	Opened		Gäst
Newsletter clicked	Thu, 07/30/2020 - 06:06	Clicked https://japan.progress.im/ja/content/%E5%8F%8C%E6%A5%B5%E6%80%A7%E9%9A%9C%E5%AE%B3%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%AA%8D%E7%9F%A5%E6%A9%9F%E8%83%BD%E9%9A%9C%E5%AE%B3%E3%81%AE%E6%A0%B9%E5%BA%95%E3%81%AB%E3%81%82%E3%82%8B%E3%82%82%E3%81%AE%E3%81		Gäst
Newsletter opened	Thu, 07/30/2020 - 06:06	Opened		Gäst
Newsletter clicked	Thu, 07/30/2020 - 06:06	Clicked https://japan.progress.im/ja/content/covid-19%E3%83%91%E3%83%B3%E3%83%87%E3%83%9F%E3%83%83%E3%82%AF%E4%B8%AD%E3%81%AB%E5%A6%8A%E5%A9%A6%E3%81%8A%E3%82%88%E3%81%B3%E7%94%A3%E5%BE%8C%E3%81%AE%E5%A5%B3%E6%80%A7%E3%81%A7%E6%8A%91%E3%81%86%E3%81%A4%E3%81%		Gäst
Newsletter opened	Thu, 07/30/2020 - 06:06	Opened		Gäst
Newsletter opened	Thu, 07/30/2020 - 06:06	Opened		Gäst
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter Test sent to:fukuda@arc-c.jp,NASU@lundbeck.com,morioka@arc-c.jp		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Fique atualizado em 5 minutos sobre Psiquiatria e Neurologia	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Thu, 07/30/2020 - 03:57	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Thu, 07/30/2020 - 03:33	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Gäst

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Thu, 07/30/2020 - 06:08	Opened		Gäst
Newsletter clicked	Thu, 07/30/2020 - 06:08	Clicked https://japan.progress.im/ja/content/covid-19%E3%83%91%E3%83%B3%E3%83%87%E3%83%9F%E3%83%83%E3%82%AF%E4%B8%AD%E3%81%AB%E5%A6%8A%E5%A9%A6%E3%81%8A%E3%82%88%E3%81%B3%E7%94%A3%E5%BE%8C%E3%81%AE%E5%A5%B3%E6%80%A7%E3%81%A7%E6%8A%91%E3%81%86%E3%81%A4%E3%81%		Gäst
Newsletter opened	Thu, 07/30/2020 - 06:08	Opened		Gäst
Newsletter clicked	Thu, 07/30/2020 - 06:06	Clicked https://japan.progress.im/ja/content/%E5%8F%8C%E6%A5%B5%E6%80%A7%E9%9A%9C%E5%AE%B3%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E8%AA%8D%E7%9F%A5%E6%A9%9F%E8%83%BD%E9%9A%9C%E5%AE%B3%E3%81%AE%E6%A0%B9%E5%BA%95%E3%81%AB%E3%81%82%E3%82%8B%E3%82%82%E3%81%AE%E3%81		Gäst
Newsletter opened	Thu, 07/30/2020 - 06:06	Opened		Gäst
Newsletter clicked	Thu, 07/30/2020 - 06:06	Clicked https://japan.progress.im/ja/content/covid-19%E3%83%91%E3%83%B3%E3%83%87%E3%83%9F%E3%83%83%E3%82%AF%E4%B8%AD%E3%81%AB%E5%A6%8A%E5%A9%A6%E3%81%8A%E3%82%88%E3%81%B3%E7%94%A3%E5%BE%8C%E3%81%AE%E5%A5%B3%E6%80%A7%E3%81%A7%E6%8A%91%E3%81%86%E3%81%A4%E3%81%		Gäst
Newsletter opened	Thu, 07/30/2020 - 06:06	Opened		Gäst
Newsletter opened	Thu, 07/30/2020 - 06:06	Opened		Gäst
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter Test sent to:fukuda@arc-c.jp,NASU@lundbeck.com,morioka@arc-c.jp		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Fique atualizado em 5 minutos sobre Psiquiatria e Neurologia	Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Thu, 07/30/2020 - 03:57	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
Newsletter opened	Thu, 07/30/2020 - 03:33	Opened		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
User created	Wed, 10/12/2022 - 13:23	User created		Gäst
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Gäst
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Gäst
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Gäst

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER